These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33522348)

  • 1. The Role of the IL-33/ST2 Immune Pathway in Autoimmunity: New Insights and Perspectives.
    Ramezani F; Babaie F; Aslani S; Hemmatzadeh M; Mohammadi FS; Gowhari-Shabgah A; Jadidi-Niaragh F; Ezzatifar F; Mohammadi H
    Immunol Invest; 2022 May; 51(4):1060-1086. PubMed ID: 33522348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-33/ST2 axis in autoimmune disease.
    Shakerian L; Kolahdooz H; Garousi M; Keyvani V; Kamal Kheder R; Abdulsattar Faraj T; Yazdanpanah E; Esmaeili SA
    Cytokine; 2022 Oct; 158():156015. PubMed ID: 36041312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the IL-33/ST2 axis in autoimmune disorders: Friend or foe?
    Liu X; Xiao Y; Pan Y; Li H; Zheng SG; Su W
    Cytokine Growth Factor Rev; 2019 Dec; 50():60-74. PubMed ID: 31085085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-33/ST2 Axis in Organ Fibrosis.
    Kotsiou OS; Gourgoulianis KI; Zarogiannis SG
    Front Immunol; 2018; 9():2432. PubMed ID: 30405626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases.
    Chen WY; Tsai TH; Yang JL; Li LC
    Cell Physiol Biochem; 2018; 49(1):349-358. PubMed ID: 30138941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-33 in autoimmunity; possible therapeutic target.
    Yuan C
    Int Immunopharmacol; 2022 Jul; 108():108887. PubMed ID: 35729828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-33/ST2 Pathway as a Rational Therapeutic Target for CNS Diseases.
    Du LX; Wang YQ; Hua GQ; Mi WL
    Neuroscience; 2018 Jan; 369():222-230. PubMed ID: 29175156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of ST2-IL18R1-IL18RAP gene cluster: a new risk for autoimmune thyroid diseases.
    Wang X; Zhu YF; Li DM; Qin Q; Wang Q; Muhali FS; Jiang WJ; Zhang JA
    Int J Immunogenet; 2016 Feb; 43(1):18-24. PubMed ID: 26566691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Opportunities of Interleukin-33 in the Central Nervous System.
    Sun Y; Wen Y; Wang L; Wen L; You W; Wei S; Mao L; Wang H; Chen Z; Yang X
    Front Immunol; 2021; 12():654626. PubMed ID: 34079543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of IL-33/ST2 pathway in acute inflammation on tissue damage, antioxidative parameters, magnesium concentration and cytokines profile.
    Stankovic MS; Janjetovic K; Velimirovic M; Milenkovic M; Stojkovic T; Puskas N; Zaletel I; De Luka SR; Jankovic S; Stefanovic S; Japundzic-Zigon N; Petronijevic ND; Trajkovic V; Trbovich AM
    Exp Mol Pathol; 2016 Aug; 101(1):31-7. PubMed ID: 27222019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical Roles of IL-33/ST2 Pathway in Neurological Disorders.
    Abd Rachman Isnadi MF; Chin VK; Abd Majid R; Lee TY; Atmadini Abdullah M; Bello Omenesa R; Osamah Ibraheem Z; Basir R
    Mediators Inflamm; 2018; 2018():5346413. PubMed ID: 29507527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Roles of IL-33/ST2 Axis in Renal Diseases.
    Chen WY; Li LC; Yang JL
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstitution of ST2 (IL-1R4) specific for IL-33 activity; no suppression by IL-1Ra though a common chain IL-1R3 (IL-1RAcP) shared with IL-1.
    Jo S; Kim E; Kwak A; Lee J; Hong J; Lee J; Youn S; Bae S; Kim B; Ryoo S; Kang TB; Her E; Choi DK; Kim YS; Lee Y; Jhun H; Kim S
    Cytokine; 2016 Jul; 83():33-40. PubMed ID: 27031441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunomodulatory of interleukin-33 in rheumatoid arthritis: A systematic review.
    Liu R; Wang F; Luo X; Yang F; Gao J; Shen H; Zheng Z
    Clin Immunol; 2024 Aug; 265():110264. PubMed ID: 38825072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL33 (Interleukin 33)/ST2 (Interleukin 1 Receptor-Like 1) Axis Drives Protective Microglial Responses and Promotes White Matter Integrity After Stroke.
    Xie D; Liu H; Xu F; Su W; Ye Q; Yu F; Austin TJ; Chen J; Hu X
    Stroke; 2021 Jun; 52(6):2150-2161. PubMed ID: 33902297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-33/ST2 Axis: A Potential Therapeutic Target in Neurodegenerative Diseases.
    Jia Z; Guo M; Ge X; Chen F; Lei P
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IL-33/ST2 axis: Role in health and disease.
    De la Fuente M; MacDonald TT; Hermoso MA
    Cytokine Growth Factor Rev; 2015 Dec; 26(6):615-23. PubMed ID: 26271893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Association of Interleukin 33/ST2 Polymorphisms With Behcet's Uveitis.
    Pei M; Liu X; Yang P; Zhao C; Gao F; Qu Y; Liang A; Xiao J; Zhang M
    Front Immunol; 2021; 12():589639. PubMed ID: 33859633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency in IL-33/ST2 Axis Reshapes Mitochondrial Metabolism in Lipopolysaccharide-Stimulated Macrophages.
    Xu H; Sun L; He Y; Yuan X; Niu J; Su J; Li D
    Front Immunol; 2019; 10():127. PubMed ID: 30774633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation.
    Takatori H; Makita S; Ito T; Matsuki A; Nakajima H
    Front Immunol; 2018; 9():2004. PubMed ID: 30233590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.